Clinical Trials Directory

Trials / Completed

CompletedNCT03866512

Forearm Immobilization, Metabolic Health, and Muscle Loss

The Impact of Acipimox and Salbutamol Supplementation on the Development of Insulin Resistance and Anabolic Resistance During Forearm Immobilization in Healthy, Young Volunteers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
37 (actual)
Sponsor
University of Exeter · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The present study will investigate the impact of altered substrate availability on muscle atrophy, insulin sensitivity and muscle protein synthesis following short-term forearm immobilization

Detailed description

Thirty-six healthy young volunteers will undergo 2 days of forearm immobilization combined with ingestion of one of two drug or placebo. Before and after immobilization, they will receive a stable isotope tracer infusion (5.5 h) combined with repeated blood and muscle sampling under insulin clamp conditions, in order to measure insulin sensitivity and muscle protein synthesis in the fasted and fed state.

Conditions

Interventions

TypeNameDescription
BEHAVIORALForearm immobilizationTwo days of forearm immobilization

Timeline

Start date
2019-05-10
Primary completion
2021-07-01
Completion
2021-07-01
First posted
2019-03-07
Last updated
2024-06-21
Results posted
2024-06-21

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03866512. Inclusion in this directory is not an endorsement.

Forearm Immobilization, Metabolic Health, and Muscle Loss (NCT03866512) · Clinical Trials Directory